Clinical Experiment of Mutant Herpes Simplex Virus HF10 Therapy for Cancer

E-ISSN： 1873-5576|7|2|169-174

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.2, 2007-03, pp. : 169-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Engineered, Naturally Oncolytic Herpes Simplex Virus HSV1 HF-10:Applications for Cancer Gene Therapy

Current Gene Therapy, Vol. 8, Iss. 3, 2008-06 ,pp. : 208-221

Bentham Science Publishers

Access to resources Recommend Favorite

Replicating herpes simplex virus vectors for cancer gene therapy

By Yeung S.N. Tufaro F.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite

Herpes Simplex Encephalitis: From Virus to Therapy

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 11, Iss. 3, 2011-06 ,pp. : 235-250

Bentham Science Publishers

Access to resources Recommend Favorite

Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery

By Gaston David C Whitley Richard J Parker Jacqueline N

Future Virology, Vol. 6, Iss. 3, 2011-03 ,pp. : 321-340

Future Medicine

Access to resources Recommend Favorite

Clinical and Therapeutic Issues for Herpes Simplex Virus-2 and HIV Co-Infection

By Lingappa Jairam R.

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 155-174

Adis International

Access to resources Recommend Favorite